Immune Pharmaceuticals Inc (fka IMNPQ)

[the_hoard]

What a somewhat interesting conversation.

Mike, the final agreement with Alexions $6M buy of Immunes sub-licenses has not be completed. How much for the data? Meaning, the true value of the deal has yet to be disclosed. Immune turned down 2 other substitive deals ranging upwards of $100M as we understand it at this point. If they baulked at these other fantastic deals, and opted for the measly $6M upfront, I wonder what the long term value is? Hmmm.

I wonder why one of the worlds largest pharmaceuticals would be in talks with a puny little bio such as Immune for well over 2 years. I wonder why the 82% efficacy for bertilimumab in relation to Bullous Pemphigoid with its steroid tapering effect only pulled in $6M. Orphan drug designation in the US and EU worth $6M? The results of the UC study never being released publicly. Hmmm.

Mike, the shares have an undisclosed range of value. We’ll find out what that is soon enough. Letterman, nothing is 100%. But, this, this is just an old fashion stakeout. You know this.